Health Care [N] » Health Services Administration [N04] » Quality of Health Care » Outcome and Process Assessment, Health Care » Outcome Assessment, Health Care » Treatment Outcome
Health Care [N] » Health Care Quality, Access, and Evaluation [N05] » Quality of Health Care » Health Care Evaluation Mechanisms » Outcome and Process Assessment, Health Care » Outcome Assessment, Health Care » Treatment Outcome
Description
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. MeSH
Hierarchy View
Subtype Terms (7)
Disease-Free Survival
12 drugs (11 approved, 1 experimental)
Early Termination of Clinical Trials
Progression-Free Survival
34 drugs (25 approved, 9 experimental)
Response Evaluation Criteria in Solid Tumors
1 approved drug
Sustained Virologic Response
5 approved drugs
Treatment Failure
6 drugs (5 approved, 1 experimental)
Phase 2 Indicated Drugs (6)
Other Experimental Indicated Drugs (9)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
